The application of cancer stem cell model in malignant mesothelioma

被引:4
作者
Bronte, Giuseppe [1 ,4 ]
Procopio, Antonio Domenico [1 ,2 ]
Graciotti, Laura [3 ]
机构
[1] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Ancona, Italy
[2] Natl Inst Hlth & Sci Ageing INRCA IRCCS, Clin Lab & Precis Med, Ancona, Italy
[3] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Via Tronto 10-A, Ancona, Italy
关键词
Malignant mesothelioma; Cancer stem cells; Chemoresistance; PLEURAL MESOTHELIOMA; IDENTIFICATION; RESISTANCE; MUTATIONS; CISPLATIN; ASBESTOS; THERAPY; MARKERS; TARGET; BAP1;
D O I
10.1016/j.critrevonc.2022.103698
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The high mortality rate of malignant pleural mesothelioma led to study the mechanisms for chemoresistance. The cancer stem cell (CSC) model has been proposed to explain chemoresistance. CSCs are characterized by self-renewal capacity, that is detected through tumor-initiating cell assays. As in other malignancies, many studies sought to identify surface markers to isolate CSCs from malignant mesothelioma. Other studies characterized malignant mesothelioma CSCs for the expression of specific genes involved in stemness and the expression of proteins involved in chemoresistance. However, the main methods to characterize isolated CSCs include sphere formation, invasiveness, tumor-initiating capacity and expression of specific surface markers. The better knowledge of malignant mesothelioma CSCs allowed exploring new potential targets to develop specific treatments.
引用
收藏
页数:7
相关论文
共 53 条
  • [51] Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
    Vogelzang, NJ
    Rusthoven, JJ
    Symanowski, J
    Denham, C
    Kaukel, E
    Ruffie, P
    Gatzemeier, U
    Boyer, M
    Emri, S
    Manegold, C
    Niyikiza, C
    Paoletti, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) : 2636 - 2644
  • [52] Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
    Wu, Licun
    Blum, Walter
    Zhu, Chang-Qi
    Yun, Zhihong
    Pecze, Laszlo
    Kohno, Mikihiro
    Chan, Mei-Lin
    Zhao, Yidan
    Felley-Bosco, Emanuela
    Schwaller, Beat
    de Perrot, Marc
    [J]. BMC CANCER, 2018, 18
  • [53] Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells
    Yamazaki, Hiroto
    Naito, Motohiko
    Ghani, Farhana Ishrat
    Dang, Nam H.
    Iwata, Satoshi
    Morimoto, Chikao
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 419 (03) : 529 - 536